Literature DB >> 22515699

Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.

Brianne Magouirk Bettcher1, Joel H Kramer.   

Abstract

A proposed immune mechanism that potentially modifies or exacerbates neurodegenerative disease presentation in older adults has received considerable attention in the past decade, with recent studies demonstrating a strong link between pro-inflammatory markers and neurodegeneration. The overarching aim of the following review is to synthesize recent research that supports a possible relationship between inflammation and clinical features of neurodegenerative diseases, including risk of development, cognitive and clinical correlates, and progression of the specified diseases. Specific emphasis is placed on providing a temporal context for the association between inflammation and neurodegeneration.

Entities:  

Mesh：

Year:  2012        PMID： 22515699      PMCID： PMC3733377          DOI： 10.1080/13554794.2011.654227

Source DB:  PubMed          Journal:  Neurocase        ISSN： 1355-4794            Impact factor:   0.881


  153 in total

Review 1.  Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.

Authors:  J J M Hoozemans; R Veerhuis; J M Rozemuller; P Eikelenboom
Journal:  Int J Dev Neurosci       Date:  2005-12-27       Impact factor: 2.457

2.  Systemic immune aberrations in Alzheimer's disease patients.

Authors:  Konstantinos Bonotis; Eleni Krikki; Vasiliki Holeva; Christina Aggouridaki; Vasiliki Costa; Stavros Baloyannis
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

3.  Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.

Authors:  Imrich Blasko; Gabriele Knaus; Elisabeth Weiss; Georg Kemmler; Christiana Winkler; Gerda Falkensammer; Andrea Griesmacher; Reinhard Würzner; Josef Marksteiner; Dietmar Fuchs
Journal:  J Psychiatr Res       Date:  2006-03-20       Impact factor: 4.791

4.  Serum inflammatory biomarkers in Parkinson's disease.

Authors:  M Dufek; M Hamanová; J Lokaj; D Goldemund; I Rektorová; Z Michálková; K Sheardová; I Rektor
Journal:  Parkinsonism Relat Disord       Date:  2008-07-30       Impact factor: 4.891

5.  The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease.

Authors:  Matthew Menza; Roseanne Defronzo Dobkin; Humberto Marin; Margery H Mark; Michael Gara; Karina Bienfait; Allison Dicke; Alex Kusnekov
Journal:  Psychosomatics       Date:  2010 Nov-Dec       Impact factor: 2.386

Review 6.  Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.

Authors:  Joshua J Gagne; Melinda C Power
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

7.  Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation.

Authors:  C A Murray; M A Lynch
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

8.  Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.

Authors:  Iwona Kurkowska-Jastrzebska; Tomasz Litwin; Ilona Joniec; Agnieszka Ciesielska; Adam Przybyłkowski; Andrzej Członkowski; Anna Członkowska
Journal:  Int Immunopharmacol       Date:  2004-10       Impact factor: 4.932

9.  Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.

Authors:  Julius Popp; Michael Bacher; Heike Kölsch; Carmen Noelker; Oliver Deuster; Richard Dodel; Frank Jessen
Journal:  J Psychiatr Res       Date:  2008-11-26       Impact factor: 4.791

10.  Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium.

Authors:  Carol Murray; David J Sanderson; Chris Barkus; Robert M J Deacon; J Nicholas P Rawlins; David M Bannerman; Colm Cunningham
Journal:  Neurobiol Aging       Date:  2010-05-14       Impact factor: 4.673
View more
  18 in total

1.  Blueberries Improve Neuroinflammation and Cognition differentially Depending on Individual Cognitive baseline Status.

Authors:  Barbara Shukitt-Hale; Nopporn Thangthaeng; Marshall G Miller; Shibu M Poulose; Amanda N Carey; Derek R Fisher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-06-18       Impact factor: 6.053

2.  SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.

Authors:  Marie-Therese Khairallah; Jacob Astroski; Sarah K Custer; Elliot J Androphy; Craig L Franklin; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

3.  Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study.

Authors:  Emmanuelle Kesse-Guyot; Karen E Assmann; Valentina A Andreeva; Mathilde Touvier; Lola Neufcourt; Nitin Shivappa; James R Hébert; Michael D Wirth; Serge Hercberg; Pilar Galan; Chantal Julia
Journal:  Eur J Nutr       Date:  2016-04-07       Impact factor: 5.614

4.  Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response.

Authors:  Peng Li; Zhaohui Li
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

Review 5.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

6.  Declines in inflammation predict greater white matter microstructure in older adults.

Authors:  Brianne Magouirk Bettcher; Kristine Yaffe; Robert M Boudreau; John Neuhaus; Howard Aizenstein; Jingzhong Ding; Stephen B Kritchevsky; Lenore J Launer; Yongmei Liu; Suzanne Satterfield; Caterina Rosano
Journal:  Neurobiol Aging       Date:  2014-11-13       Impact factor: 4.673

Review 7.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

8.  Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition.

Authors:  Konstantinos Arfanakis; Debra A Fleischman; Giorgia Grisot; Christopher M Barth; Anna Varentsova; Martha C Morris; Lisa L Barnes; David A Bennett
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

9.  Interleukin-6, age, and corpus callosum integrity.

Authors:  Brianne M Bettcher; Christa L Watson; Christine M Walsh; Iryna V Lobach; John Neuhaus; Joshua W Miller; Ralph Green; Nihar Patel; Shubir Dutt; Edgar Busovaca; Howard J Rosen; Kristine Yaffe; Bruce L Miller; Joel H Kramer
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

10.  Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.

Authors:  Paola Italiani; Cecilia Carlesi; Paola Giungato; Ilaria Puxeddu; Barbara Borroni; Paola Bossù; Paola Migliorini; Gabriele Siciliano; Diana Boraschi
Journal:  J Neuroinflammation       Date:  2014-05-23       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.